Cabozantinib as a successful salvage therapy in chemo-refractory Ewing sarcoma

Yair Peled; Dror Levin; Shelly Shiran; Michal Manisterski; Ronit Elhasid

doi:10.1002/pbc.29976

Cabozantinib as a successful salvage therapy in chemo-refractory Ewing sarcoma

Yair Peled
, Dror Levin
, Shelly Shiran
, Michal Manisterski
, Ronit Elhasid^*

^*Corresponding author for this work

Pediatrics

Tel Aviv University

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Article number	e29976
Journal	Pediatric Blood and Cancer
Volume	70
Issue number	3
DOIs	https://doi.org/10.1002/pbc.29976
State	Published - Mar 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/pbc.29976

Cite this

@article{1f80e39c84814bd1bf661a18f8f9210d,

title = "Cabozantinib as a successful salvage therapy in chemo-refractory Ewing sarcoma",

author = "Yair Peled and Dror Levin and Shelly Shiran and Michal Manisterski and Ronit Elhasid",

year = "2023",

month = mar,

doi = "10.1002/pbc.29976",

language = "אנגלית",

volume = "70",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "3",

}

TY - JOUR

T1 - Cabozantinib as a successful salvage therapy in chemo-refractory Ewing sarcoma

AU - Peled, Yair

AU - Levin, Dror

AU - Shiran, Shelly

AU - Manisterski, Michal

AU - Elhasid, Ronit

PY - 2023/3

Y1 - 2023/3

UR - https://www.scopus.com/pages/publications/85137537450

U2 - 10.1002/pbc.29976

DO - 10.1002/pbc.29976

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 36070192

AN - SCOPUS:85137537450

SN - 1545-5009

VL - 70

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 3

M1 - e29976

ER -

Cabozantinib as a successful salvage therapy in chemo-refractory Ewing sarcoma

UN SDGs

Access to Document

Other files and links

Cite this